Market Tracker

05/05 6:45pm ET

NxStage Medical Inc (NASDAQ:NXTM)

16.18
Delayed Data
As of 3:59pm ET
 -0.59 / -3.52%
Today’s Change
13.47
Today|||52-Week Range
22.60
-26.15%
Year-to-Date

Today’s Trading

Previous close16.77
Today’s open16.68
Day’s range16.01 - 16.82
Volume447,229
Average volume (3 months)539,033
Market cap$1.1B
Dividend yield--
Data as of 3:59pm ET, 05/05/2016

Growth & Valuation

Earnings growth (last year)+38.46%
Earnings growth (this year)+35.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+11.48%
P/E ratioNM
Price/Sales4.13
Price/Book5.60

Competitors

 Today’s
change
Today’s
% change
FGENFibroGen Inc-0.33-1.99%
EXELExelixis Inc+0.36+8.31%
ABCOAdvisory Board Co-1.10-3.61%
LXRXLexicon Pharmaceutic...+0.24+2.00%
Data as of 3:59pm ET, 05/05/2016

Financials

Next reporting dateAugust 3, 2016
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$336.1M
Annual profit (last year)-$15.3M
Net profit margin-4.56%

Profile

Sector
Health Technology
Industry
Medical Specialties
Chief Executive Officer &
Director
Jeffrey H. Burbank
President
Joseph E. Turk
Corporate headquarters
Lawrence, Massachusetts

Forecasts